Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 2
1985 2
1987 3
1988 1
1989 1
1990 3
1991 2
1992 5
1993 4
1994 5
1995 8
1996 7
1997 10
1998 11
1999 14
2000 23
2001 32
2002 37
2003 40
2004 41
2005 51
2006 62
2007 78
2008 72
2009 96
2010 115
2011 154
2012 157
2013 207
2014 217
2015 232
2016 271
2017 283
2018 357
2019 477
2020 564
2021 644
2022 795
2023 119
Text availability
Article attribute
Article type
Publication date

Search Results

4,605 results
Results by year
Filters applied: . Clear all
Page 1
Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer.
Ouyang S, Li H, Lou L, Huang Q, Zhang Z, Mo J, Li M, Lu J, Zhu K, Chu Y, Ding W, Zhu J, Lin Z, Zhong L, Wang J, Yue P, Turkson J, Liu P, Wang Y, Zhang X. Ouyang S, et al. Among authors: zhu k. Redox Biol. 2022 Jun;52:102317. doi: 10.1016/j.redox.2022.102317. Epub 2022 Apr 21. Redox Biol. 2022. PMID: 35483272 Free PMC article.
Tumor-associated macrophages are shaped by intratumoral high potassium via Kir2.1.
Chen S, Cui W, Chi Z, Xiao Q, Hu T, Ye Q, Zhu K, Yu W, Wang Z, Yu C, Pan X, Dai S, Yang Q, Jin J, Zhang J, Li M, Yang D, Yu Q, Wang Q, Yu X, Yang W, Zhang X, Qian J, Ding K, Wang D. Chen S, et al. Among authors: zhu k. Cell Metab. 2022 Nov 1;34(11):1843-1859.e11. doi: 10.1016/j.cmet.2022.08.016. Epub 2022 Sep 13. Cell Metab. 2022. PMID: 36103895
International expert consensus on immunotherapy for early-stage non-small cell lung cancer.
Liang W, Cai K, Cao Q, Chen C, Chen H, Chen J, Chen KN, Chen Q, Chu T, Dong Y, Fan J, Fang W, Fu J, Fu X, Gao S, Ge D, Geng G, Geng Q, He J, Hu J, Hu J, Hu WD, Jiang F, Jiang T, Jiao W, Li HC, Li Q, Li S, Li S, Li X, Liao YD, Liu C, Liu H, Liu Y, Lu Z, Luo Q, Ma H, Pan X, Qiao G, Ren S, Shen W, Song Y, Sun D, Wang G, Wang J, Wang M, Wang Q, Wang WX, Wei L, Wu M, Wu N, Xia H, Xu SD, Yang F, Yang K, Yang Y, Yu F, Yu ZT, Yue DS, Zhang L, Zhang W, Zhang Z, Zhao G, Zhao J, Zhao X, Zhou C, Zhou Q, Zhu K, Zhu Y, Hida T, Dempke WCM, Rossi A, de Perrot M, Ramirez RA, Provencio M, Lee JM, Passaro A, Spaggiari L, Spicer J, Girard N, Forde PM, Mok TSK, Cascone T, He J. Liang W, et al. Among authors: zhu k. Transl Lung Cancer Res. 2022 Sep;11(9):1742-1762. doi: 10.21037/tlcr-22-617. Transl Lung Cancer Res. 2022. PMID: 36248334 Free PMC article. Review. No abstract available.
Pair-switching rerandomization.
Zhu K, Liu H. Zhu K, et al. Biometrics. 2022 Jun 27. doi: 10.1111/biom.13712. Online ahead of print. Biometrics. 2022. PMID: 35758335
Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition).
Sun J, Guo R, Bi X, Wu M, Tang Z, Lau WY, Zheng S, Wang X, Yu J, Chen X, Fan J, Dong J, Chen Y, Cui Y, Dai C, Fang C, Feng S, Ji Z, Jia W, Jia N, Li G, Li J, Li Q, Li J, Liang T, Liu L, Lu S, Lv Y, Mao Y, Meng Y, Meng Z, Shen F, Shi J, Sun H, Tao K, Teng G, Wan X, Wen T, Wu L, Xia J, Ying M, Zhai J, Zhang L, Zhang X, Zhang Z, Zhao H, Zheng D, Zhi X, Zhou J, Zhou C, Zhou J, Zeng Z, Zhu K, Chen M, Cai J, Cheng S. Sun J, et al. Among authors: zhu k. Liver Cancer. 2022 Mar 17;11(4):315-328. doi: 10.1159/000523997. eCollection 2022 Jul. Liver Cancer. 2022. PMID: 35978596 Free PMC article.
PI3K/AKT/mTOR-Targeted Therapy for Breast Cancer.
Zhu K, Wu Y, He P, Fan Y, Zhong X, Zheng H, Luo T. Zhu K, et al. Cells. 2022 Aug 12;11(16):2508. doi: 10.3390/cells11162508. Cells. 2022. PMID: 36010585 Free PMC article. Review.
Remodelling of tumour microenvironment by microwave ablation potentiates immunotherapy of AXL-specific CAR T cells against non-small cell lung cancer.
Cao B, Liu M, Wang L, Zhu K, Cai M, Chen X, Feng Y, Yang S, Fu S, Zhi C, Ye X, Zhang J, Zhang Z, Yang X, Zhao M, Wu Q, Xu L, Yang L, Lian H, Zhao Q, Zhang Z. Cao B, et al. Among authors: zhu k. Nat Commun. 2022 Oct 19;13(1):6203. doi: 10.1038/s41467-022-33968-5. Nat Commun. 2022. PMID: 36261437 Free PMC article.
4,605 results